ArticleThe Journal of infectious diseases2025
Outcomes of Human Metapneumovirus Infections in Nursing Home Residents: A Matched Cohort Analysis.
Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Global Burden of Human Metapneumovirus in High-Risk Adults: A Systematic Literature Review and Meta-Analysis.Journal of epidemiology and global health · 2026Pooled it
- The Diabetes-Viral Respiratory Syndemic: Pathophysiological Insights and Precision Management: A Scoping Review.Medicina (Kaunas, Lithuania) · 2026Article
- Review: Knowledge Gained and Gaps in Understanding in the 25 Years Since Human Metapneumovirus Was First Identified as a Cause of Human Disease.The Journal of infectious diseases · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdentified in 2001, human metapneumovirus (hMPV) infection can lead to hospitalization and death, especially in older adults and children.
methodsThis retrospective, propensity-matched study compared cases of hMPV infection with cases of influenza virus and respiratory syncytial virus (RSV) infection for hospitalization and death outcomes in older adults living in Community Living Centers (CLCs), nursing homes operated by the US Department of Veterans Affairs. We evaluated electronic medical records from July 2017 to June 2024. We included CLC residents with laboratory-confirmed hMPV, influenza virus, or RSV infections. The propensity-matched analysis balanced demographic and clinical characteristics. Proportional hazards models estimated the risk of hospitalization, death or the combined outcome over the 90 days after diagnosis.
resultsWe identified 178 hMPV, 1379 influenza virus, and 681 RSV laboratory-confirmed infections. In the propensity analysis. Residents with hMPV infection (n = 173) were well matched to those with influenza virus infection (n = 746). The matched cohort proportional hazard analysis (hMPV vs influenza virus infection) showed similar hazards for 90-day outcomes of hospitalization (adjusted hazard ratio, 1.00 [95% confidence interval, .67-1.49]), death (0.79 [.48-1.29]), or both combined (0.81 [.58-1.12]). With use of similar methods, residents with hMPV (n = 170) were well matched to those with RSV (n = 437). The matched cohort proportional hazard analysis showed similar 90-day outcomes of hospitalization (adjusted hazard ratio, 1.00 [95% confidence interval, .66-1.51)], death (0.93 [.58-1.56], or both combined (0.97 [.68-1.37]).
conclusionsResident infection with hMPV produced similar likelihoods of hospitalization and death as infection with influenza virus or RSV. Increased understanding of hMPV and appropriate testing are needed to accurately detect, prevent, and manage hMPV in nursing homes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.